About Fougera Pharmaceuticals Inc.
Fougera Pharmaceuticals (formerly Nycomed US) is focused on making specialty topical and dermatology medicines for North Americans. The company's E. Fougera & Company division primarily makes generic topical steroids, antibiotics, and antifungals for both prescription and OTC markets, while the PharmaDerm unit develops, manufactures, and markets branded prescription dermatology products. Its smaller Savage Laboratories unit makes prescription topicals for the emergency care market. Fougera separated from former parent
Fougera operates two manufacturing facilities in New York State.
Sales and Marketing
The company's PharmaDerm prescription products are marketed to health care professionals (especially dermatologists) through its direct sales force (located in New York), while Fougera & Co.'s generic offerings are supplied by sales representatives (located in New Jersey) and through wholesale distributors and retail outlets. Savage Labs sells surgical lubricant Surgilube and emergency cardiology ointment Nitro-Bid to hospital pharmacies; it stopped marketing two other products, Crofab (antivenin for snake bites) and Digifab (an antidote for digitalis poisoning).
The company has grown its operations over the years through both internal research and development efforts and through selective acquisitions.
Formerly owned by
60 Baylis Rd
Melville, NY 11747-3838
Phone: 1 (631) 454-7677
Employer Type: Privately Owned
Director FpandA: Frank Dona
EXECUTIVE LEGAL SECRETARY: Carol Lahmann
Director Of Validation: Charles Tiranno
Employees (This Location): 250
Employees (All Locations): 880